Massimo Puoti

22.0k total citations · 2 hit papers
263 papers, 9.1k citations indexed

About

Massimo Puoti is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Massimo Puoti has authored 263 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Hepatology, 175 papers in Epidemiology and 90 papers in Infectious Diseases. Recurrent topics in Massimo Puoti's work include Hepatitis C virus research (197 papers), Liver Disease Diagnosis and Treatment (114 papers) and Hepatitis B Virus Studies (105 papers). Massimo Puoti is often cited by papers focused on Hepatitis C virus research (197 papers), Liver Disease Diagnosis and Treatment (114 papers) and Hepatitis B Virus Studies (105 papers). Massimo Puoti collaborates with scholars based in Italy, United States and United Kingdom. Massimo Puoti's co-authors include Heiner Wedemeyer, Francesco Negro, Geoffrey Dusheiko, Alessio Aghemo, Marina Berenguer, Olav Dalgård, Jean–Michel Pawlotsky, Francesco Donato, Vincent Soriano and Raffaele Bruno and has published in prestigious journals such as Science, The Lancet and Nature Communications.

In The Last Decade

Massimo Puoti

243 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EASL Recommendations on Treatment of Hepatitis C 2018

2018 1.5k citations Alessio Aghemo, Massimo Puoti et al. Journal of Hepatology profile →
EASL recommendations on treatment of hepatitis C: Final update of the series☆

2020 707 citations Alessio Aghemo, Massimo Puoti et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Massimo Puoti

Since Specialization

Citations

This map shows the geographic impact of Massimo Puoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Puoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Puoti more than expected).

Fields of papers citing papers by Massimo Puoti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Puoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Puoti. The network helps show where Massimo Puoti may publish in the future.

Co-authorship network of co-authors of Massimo Puoti

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Puoti. A scholar is included among the top collaborators of Massimo Puoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Puoti. Massimo Puoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 2025 ·Infectious Diseases and Therapy ·Marta Colaneri, Marta Canuti, G Torrigiani, (unknown), (unknown), (unknown), (unknown), Massimo Puoti, (unknown), Simone Piva, Pierluigi Plebani, Mario Raviǵlione, Andrea Gori, Danilo Cereda, Olivia Leoni, Ida Fortino, (unknown), Marta Baviera, Mauro Tettamanti, (unknown)	0
2	Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection Control 2025 ·Microorganisms ·(unknown), Giovanna Travi, (unknown), (unknown), (unknown), (unknown), (unknown), Alessandra Bielli, Elisa Matarazzo, (unknown), (unknown), Roberto Rossotti, Marco Merli, Chiara Vismara, Fulvio Crippa, Stefano Martinelli, Massimo Puoti	0
3	OC-66 Socio-demographic, clinical and therapeutic features of persons with HIV (PWH) currently in care in Italy: data from the ICONA cohort 2024 ·Antonella d’Arminio Monforte, (unknown), Iuri Fanti, Carlo Federico Perno, Daniela Segala, Antonella Santoro, (unknown), Leonardo Calza, Anna Carraro, Antonella Cingolani, Massimo Puoti, Antonella Castagna, Sergio Lo Caputo, (unknown), Andrea Antinori	0
4	Meropenem–Vaborbactam for the Treatment of Post-Neurosurgical Meningitis Caused by KPC Producer Klebsiella Pneumoniae: A Case Report and Review of the Literature 2024 ·Antibiotics ·(unknown), (unknown), (unknown), Gabriele Bassi, Marco Merli, (unknown), Giovanna Travi, Fulvio Crippa, Massimo Puoti	5
5	Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak 2024 ·Antibiotics ·Giovanna Travi, (unknown), Marco Merli, (unknown), Elisa Matarazzo, (unknown), Alessandra Bielli, (unknown), Fulvio Crippa, Chiara Vismara, Massimo Puoti	2
6	Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis 2023 ·Therapeutics and Clinical Risk Management ·Felice Nava, Alessandra Mangia, (unknown), Lorenzo Somaini, Francesco Giuseppe Foschi, Ernesto Claar, Ivana Maida, Claudio Ucciferri, Francesca Frigerio, (unknown), (unknown), Valentina Perrone, Luca Degli Esposti, Massimo Puoti	1
7	Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 2023 ·Liver International ·Antonella d’Arminio Monforte, Alessandro Tavelli, Roberto Rossotti, Roberta Gagliardini, Annalisa Saracino, Sergio Lo Caputo, (unknown), Eugenia Quirós-Roldán, Cristina Mussini, Enrico Girardi, Alessandro Cozzi‐Lepri, Andrea Antinori, Massimo Puoti, (unknown)	1
8	Obesity and Dysmetabolic Factors among Deceased COVID-19 Adults under 65 Years of Age in Italy: A Retrospective Case-Control Study 2022 ·Viruses ·Loreta A. Kondili, Maria Giovanna Quaranta, Mauro Viganò, (unknown), (unknown), Cinzia Lo Noce, Luigi Palmieri, Graziano Onder, Federico D’Amico, Elvira Inglese, Massimo Puoti, Alessio Aghemo, Maria Elena Tosti	2
9	Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare. 2021 ·SHILAP Revista de lepidopterología ·(unknown), Francesco Gaudio, (unknown), (unknown), (unknown), Massimo Puoti, Arianna Pani, Frine Eleonora Scaglione, (unknown), (unknown), Oscar Massimiliano Epis, (unknown), (unknown), Marcelo Moreno, (unknown)	4
10	Home-based COVID 19 management: A consensus document from Italian general medical practitioners and hospital consultants in the Lombardy region (Italy) 2020 ·European Journal of Internal Medicine ·Nuccia Morici, Massimo Puoti, (unknown), (unknown), (unknown), Stefano Savonitto	2
11	Optimization of hepatitis C virus screening strategies by birth cohort in Italy 2020 ·Liver International ·Loreta A. Kondili, Ivane Gamkrelidze, Sarah Blach, Andrea Marcellusi, Massimo Galli, Salvatore Petta, Massimo Puoti, Stefano Vella, Homie Razavi, Antonio Craxı̀, Francesco Saverio Mennini, (unknown)	31
12	Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy 2020 ·IJC Heart & Vasculature ·Enrico Ammirati, Giovanna Travi, (unknown), Alice Sacco, (unknown), Maria Frigerio, Massimo Puoti	4
13	Single‐center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients 2018 ·Transplant Infectious Disease ·Giacomo Veronese, Enrico Ammirati, (unknown), Rossella Baldan, (unknown), (unknown), Silvio Veronese, (unknown), Enrico Perna, Giovanna Travi, Massimo Puoti, Manlio Cipriani, Simon Tiberi, Daniela María Cirillo, Maria Frigerio	14
14	Use of Daclatasvir in HCV/HIV-Coinfected Patients in a Real-Life Setting. 2017 ·PubMed ·Stefano Bonora, Massimo Puoti	6
15	Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis Network. 2016 ·PubMed ·Alessio Aghemo, Raffaele Bruno, Massimo Colombo, (unknown), Massimo Puoti, Giuliano Rizzardini, S. Fagiuoli	1
16	Triple therapy with boceprevir or telaprevir in a E uropean cohort of cirrhotic HIV / HCV genotype 1‐coinfected patients 2015 ·Liver International ·Patrick Miailhes, Camille Gilbert, Karine Lacombe, Joop E. Arends, Massimo Puoti, Jürgen K. Rockstroh, Philippe Sogni, Hélène Fontaine, Éric Rosenthal, María Winnock, (unknown), Linda Wittkop, François Dabis, Dominique Salmon, (unknown)	5
17	OPERA : responses to peginterferon and ribavirin therapy in a subgroup of interferon‐naïve patients with HIV / HCV genotype 2/3 co‐infection in Italy 2014 ·Liver International ·Raffaele Bruno, Giuseppe Cariti, Paola Nasta, Amedeo Capetti, Veronica Ravasio, Massimo Galli, Enzo Raise, (unknown), Claudio Iannacone, Massimo Puoti	4
18	Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference 2014 ·Journal of Hepatology ·S. Fagiuoli, Agostino Colli, Raffaele Bruno, Antonio Craxı̀, Giovanni Battista Gaeta, Paolo Grossi, Mario U. Mondelli, Massimo Puoti, Evangelista Sagnelli, Stefania Stefani, Pierluigi Toniutto, Patrizia Burra	74
19	Antiretroviral Therapy in HIV/HCV Co-Infection Italian Consensus Workshop 2013 ·Advances in Infectious Diseases ·Paola Nasta, Anna Maria Cattelan, Ivana Maida, Francesca Gatti, (unknown), Massimo Puoti, Giampiero Carosi	0
20	Effect of Highly Active Antiretroviral Therapy (HAART) and Hepatitis C Co-Infection on Hyperlipidemia in HIV-Infected Patients: A Retrospective Longitudinal Study 2002 ·HIV Clinical Trials ·(unknown), Carlo Torti, (unknown), Eugenia Quirós-Roldán, Davide Bertelli, Massimo Puoti, (unknown), (unknown), Carmine Tinelli, Giampiero Carosi, Francesco Castelli, (unknown)	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact